Respreeza (human alpha-1-proteinase inhibitor): Batch-specific product recall
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Respreeza
|
| Active substance |
alpha1-proteinase inhibitor (human)
|
| Therapeutic area (MeSH) |
Lung Diseases
|
| DHPC type |
Quality defect
|
| Human ATC code |
B02AB02
|
| Dissemination date |
12/02/2021
|
| Related medicines |
Respreeza
|